About GT Biologics
GT Biologics is a company based in Shoreview (United States) founded in 2007 by Denise Kelly was acquired by 4D pharma in June 2014.. GT Biologics operates in a competitive market with competitors including Novozymes, Ironwood Pharma, Evelo Biosciences, RedHill Biopharma and Alcresta, among others.
- Headquarter Shoreview, United States
- Founders Denise Kelly
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of GT Biologics
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2012 | Amount | Series A - GT Biologics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GT Biologics
GT Biologics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include 4D pharma and Aquarius Equity Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life Science focused VC firm investing in the US & UK
|
Founded Year | Domain | Location | |
|
Drugs from gut bacteria are developed for multiple diseases.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GT Biologics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GT Biologics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gt Biologics Comparisons
Competitors of GT Biologics
GT Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novozymes, Ironwood Pharma, Evelo Biosciences, RedHill Biopharma and Alcresta, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biosolutions and enzymes are developed for biotechnology applications across industries.
|
|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for inflammatory diseases, COVID-19, and cancer are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases
|
|
| domain | founded_year | HQ Location |
Enzyme-based products for gastrointestinal disorders are developed using immobilization technology.
|
|
| domain | founded_year | HQ Location |
Synbiotics are developed for simulating the gut microbiome.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about GT Biologics
When was GT Biologics founded?
GT Biologics was founded in 2007 and raised its 1st funding round 5 years after it was founded.
Where is GT Biologics located?
GT Biologics is headquartered in Shoreview, United States. It is registered at Shoreview, Minnesota, United States.
What does GT Biologics do?
GT Biologics was founded in 2007 and is based in Shoreview, United States. Operations focus on the biotechnology sector, where naturally occurring human bacteria are developed into biotherapeutics targeting gastrointestinal diseases such as Crohns disease. Intellectual property has been established around specific bacterial strains. The lead product remains in preclinical development for Crohns disease treatment.
Who are the top competitors of GT Biologics?
GT Biologics's top competitors include Novozymes, Ironwood Pharma and Ardelyx.
Who are GT Biologics's investors?
GT Biologics has 2 investors. Key investors include 4D pharma, and Aquarius Equity Partners.